ES485105A1 - Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno - Google Patents

Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Info

Publication number
ES485105A1
ES485105A1 ES485105A ES485105A ES485105A1 ES 485105 A1 ES485105 A1 ES 485105A1 ES 485105 A ES485105 A ES 485105A ES 485105 A ES485105 A ES 485105A ES 485105 A1 ES485105 A1 ES 485105A1
Authority
ES
Spain
Prior art keywords
adeno
newcastle disease
viruses
active against
drop caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485105A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES485105A1 publication Critical patent/ES485105A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedimiento para la preparación de un líquido inicial que contiene virus de tipo adeno, para la preparación de una vacuna inactivada combinada dispuesta para administración, caracterizado porque un virus de tipo adeno se cultiva en huevos de pato o en un cultivo celular, tal como un cultivo en frascos rodantes de monocapa o un cultivo de células unidas a vehículos inertes sólidos, de fibroblastos de embrión de pato.
ES485105A 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno Expired ES485105A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7809364 1978-09-14
NL7903300 1979-04-26

Publications (1)

Publication Number Publication Date
ES485105A1 true ES485105A1 (es) 1980-06-16

Family

ID=26645447

Family Applications (2)

Application Number Title Priority Date Filing Date
ES484187A Expired ES484187A1 (es) 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
ES485105A Expired ES485105A1 (es) 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES484187A Expired ES484187A1 (es) 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno

Country Status (10)

Country Link
US (1) US4537768A (es)
EP (1) EP0009277B1 (es)
DE (1) DE2966914D1 (es)
DK (1) DK157732C (es)
ES (2) ES484187A1 (es)
FR (1) FR2435949A1 (es)
GR (1) GR70272B (es)
IE (1) IE48482B1 (es)
LU (1) LU81687A1 (es)
PT (1) PT70156A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812359A (nl) * 1978-12-20 1980-06-24 Gist Brocades Nv Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
FR2706665B1 (fr) * 1993-06-11 1995-09-08 Fis Dispositif pour la fixation d'un boîtier d'affichage électronique.
RU2167673C1 (ru) * 2000-09-04 2001-05-27 Всероссийский научно-исследовательский институт защиты животных Набор для определения антител к вирусу синдрома снижения яйценоскости-76 кур

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292949A (es) *
US3083142A (en) * 1958-02-27 1963-03-26 Glaxo Group Ltd Improved swine erysipelas vaccine
US3060094A (en) * 1959-04-07 1962-10-23 Ray M Dutcher Preparation of virus vaccines
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
NL7012832A (es) * 1970-08-29 1972-03-02
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
JPS529727B2 (es) * 1971-12-29 1977-03-18
JPS506714A (es) * 1973-05-31 1975-01-23
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
JPS529727A (en) * 1975-07-11 1977-01-25 Toyota Motor Corp Carburettor
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations

Also Published As

Publication number Publication date
EP0009277B1 (en) 1984-04-18
US4537768A (en) 1985-08-27
PT70156A (en) 1979-10-01
LU81687A1 (fr) 1981-04-17
ES484187A1 (es) 1980-04-01
GR70272B (es) 1982-09-03
DE2966914D1 (en) 1984-05-24
IE791745L (en) 1980-03-14
FR2435949B1 (es) 1984-05-18
IE48482B1 (en) 1985-02-06
FR2435949A1 (fr) 1980-04-11
DK157732B (da) 1990-02-12
EP0009277A1 (en) 1980-04-02
DK383079A (da) 1980-03-15
DK157732C (da) 1990-07-09

Similar Documents

Publication Publication Date Title
ES2068249T3 (es) Preparacion de glicerol propoxilado esterificado con calidad de alimentacion a partir de acidos grasos libres.
CA2008856C (en) Tocols as adjuvant in vaccine
US4761282A (en) Inactivated infectious bronchitis vaccine for poultry
ES2052564T3 (es) Procedimiento para la produccion de acido bishomo-gamma-linolenico y acido eicosapanteonico.
US3655871A (en) Inactivation of influenza viruses with lower alkyl esters of acetic acid
DE3473825D1 (en) Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
ES484187A1 (es) Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
KR840005347A (ko) 정제된 조류의 전위염 레오바이러스분리법 및 전위염백신의 제조방법
SE7908929L (sv) Fettemulsion for intravenos injektion
US4505892A (en) Infectious bronchitis vaccine for poultry
ES8105150A1 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US4500638A (en) Infectious bronchitis virus strain
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
Aitken et al. Observations on the serological and dermal responses of turkeys to a single subcutaneous inoculation of inactivated Newcastle disease vaccine in mineral oil adjuvant
US4515777A (en) Vaccines
JPS63126493A (ja) 抗ウイルス剤
SE8001236L (sv) Forfarande for framstellning av kasein med lag kolesterolhalt
USRE34013E (en) Infectious bronchitis vaccine for poultry
JPS5656223A (en) Starch sugar ester
IL102297A0 (en) Marek's disease vaccine
GB551246A (en) Improvements in or relating to sulphonated compounds
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
Whitehead New Apion (Coelocephalapion) species (Curculionidae: Apioninae) from fruits of Pterocarpus (Leguminosae: Faboideae) in Central America
GB1375544A (es)